Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TRANDOLAPRIL\VERAPAMIL vs TRASTUZUMAB DERUXTECAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TRANDOLAPRIL\VERAPAMIL vs TRASTUZUMAB DERUXTECAN: Safety Overview

Metric TRANDOLAPRIL\VERAPAMIL TRASTUZUMAB DERUXTECAN
Total FAERS Reports 270 2,684
Deaths Reported 41 653
Death Rate 15.2% 24.3%
Hospitalizations 124 780
Average Patient Age 64.8 yrs 56.5 yrs
% Female Patients 48.4% 91.9%
Manufacturer N/A Daiichi Sankyo Inc.
Route N/A INTRAVENOUS